NFE2L2 and focal segmental glomerulosclerosis: In a doxorubicin-induced mouse model of focal segmental glomerulosclerosis, astaxanthin elicits significant improvements in glomerular and interstitial fibrosis by promoting Nrf2 expression and inhibiting the NLRP3 inflammasome (Liu et al., 2015).